Oramed Pharmaceuticals, Inc. (ORMP) has gained Thursday morning, with the stock climbing 11.21% in pre-market trading to 3.57. ORMP's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 109 out of 146 industries, Oramed Pharmaceuticals, Inc. ranks higher than 61% of stocks. Oramed Pharmaceuticals, Inc. has risen 45.25% over the past month, closing at $2.27 on January 25. During this period of time, the stock fell as low as $2.27 and as high as $3.29. ORMP has an average analyst recommendation of Sell. The company has an average price target of $4.25.
ORMP has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ORMP!